Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
SRx Health Solutions, Inc. reported the fourth quarter ended December 31, 2022 results: revenue $9.3 million, net income $24.4 million.
- Period
- the fourth quarter ended December 31, 2022
- Revenue
- $9.3 million
- Net income
- $24.4 million
- Result
- reported results
Exact text from the filing
results for the fourth quarter and year ended December 31, 2022. Lionel F. Conacher, Interim CEO of Better Choice, stated, “During the fourth quarter, net sales were sales were $9.3 million resulting in full year 2022 net sales of $54.7 million, a 19% increase versus the prior year. Our International channel delivered year-over-year net sales growth of 48% and Brick
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
SRx Health Solutions, Inc. reported the year ended December 31, 2022 results: revenue $54.7 million, net income $(39.3) million.
- Period
- the year ended December 31, 2022
- Revenue
- $54.7 million
- Net income
- $(39.3) million
- Result
- reported results
Exact text from the filing
and Current Reports on Form 8-K. --- EX-99.1 (EX-99.1) --- Better Choice Company Reports Fourth Quarter and Full Year 2022 Financial Results Year-to-Date Net Sales Totaled $54.7 million, an Increase of 19% Year-over-Year Year-to-Date Gross Margin of 28%, or 31% Excluding the Impact of Inventory Rationalization NEW YORK, NY, March 28, 2023 -- Better Choice
View on SEC.gov